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J.R. Schneider*
Vascular and Interventional Program of Central DuPage Hospital, Northwestern University Medical School, Outpatient Services Building Suite 201, 25 North Winﬁeld Road, Winﬁeld,
IL 60190, USADr. Mann and colleagues have presented a clear review of the
experience with blood cross matching and transfusion over the 10
year evolution of endovascular aneurysm repair (EVAR) in a single
hospital. The total experience in elective EVAR was 203 subjects,
but the authors state that their current practice is about 60 cases
per year. These numbers are likely comparable to an average
general hospital of 250e500 beds and the sample size is clearly
adequate to support a careful analysis and conclusions.
It is reassuring that 94% of their elective EVARs required no
transfusion. However, those who did require transfusion required
massive transfusion in half of the cases. The authors point out that
patients who are found to have unusual antibodies are a special
case and that cross matched blood should be available for such
cases. Shed blood salvage is likely far more expensive than cross
matching blood, although it makes transfusion complications less
likely thanwith non-autologous blood. As more andmore EVAR are
performed percutaneously the use of shed blood salvage systems
becomes irrelevant unless the operation is converted to open
repair. The authors also describe the general requirement for an
emergency transfusion plan, availability of type O Rh negative red
blood cells, and the standards for maximum time to provide typeDOI of original article: 10.1016/j.ejvs.2011.11.026.
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doi:10.1016/j.ejvs.2011.12.008speciﬁc cells and crossmatched cells. However they offer no patient
factors that might be useful in predicting patients at higher risk of
requiring transfusion, especially massive transfusion. It is not clear
to me which would be more important in practice, i.e., are patients
with unusual antibodies more common than patients with
anatomy or other factors that might predict a greater risk of
signiﬁcant blood loss associated with EVAR?
The authors make a compelling case that the standard for
maximum surgical blood order schedule for EVAR should be group
and save (type and screen or type and hold). We have adopted
a type and screen policy for elective EVAR and have thus far not
required activation of an emergency transfusion protocol in any
case. The remaining challenge is to identify factors that predict
a higher risk of requiring transfusion and in whom there may be
a separate MSBOS. Anatomic challenges such as small diameter or
tortuous iliac arteries and angulation are a continuum and it is
highly unlikely that there will be discrete anatomic thresholds for
increased risk of hemorrhage during EVAR. Careful review of
patient (including anatomic) factors during planning of EVAR will
likely identify patients for whom the surgeon feels compelled to
have cross matched blood on hand.d by Elsevier Ltd. All rights reserved.
